Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -76.6411.90-35.99-579.49-62.36

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -76.64 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar2026-76.64
Mar202511.90
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2026 -76.64
Negative
Mar2025 11.9
Positive
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹203.5 Cr -7.5% 12.2% -27% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,791.0 Cr 1.7% -1.4% 21.7% Stock Analytics
DIVIS LABORATORIES ₹245,081.0 Cr 2% 10.3% 49.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,351.0 Cr -0.4% -0.5% 38.6% Stock Analytics
CIPLA ₹114,163.0 Cr -0.5% -2.5% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.3 Cr -1.2% 0% -7.1% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-7.5%

12.2%

-27%

SENSEX

-1.2%

-2.6%

-5.2%


You may also like the below Video Courses